Welcome!

News Feed Item

Global Neurotechnology Industry 2014 Report: Company Profiles and Pipeline Analysis from Over 500 Companies and 20 Illnesses

DUBLIN, IRELAND -- (Marketwired) -- 08/15/14 -- Research and Markets (http://www.researchandmarkets.com/research/s7qvsb/the) has announced the addition of a new report "Neurotech Industry 2014 Report" to their offering.

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 20 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights:

--  More than 500 profiles of public and private neurotech companies
    including drugs, devices and diagnostics
--  Pipelines and market analysis for 20 brain and nervous system illnesses
    including: addiction, Alzheimer's disease, anxiety, attention disorders,
    depression, epilepsy, hearing loss, insomnia, mild cognitive impairment,
    migraine, multiple sclerosis, obesity, pain, Parkinson's disease,
    retinal disorders, schizophrenia, stroke, and traumatic brain injury
--  Top neurotech investors, venture capital firms, and venture capital
    trends (1999-Q12014)
--  Neurotech IPOs (2004-Q12014), M&A (2004-Q12014), Partnering and
    Licensing deals (2005-Q12014) and public neurotech stock performance
--  Analysis of biological basis, current treatment options, and emerging
    therapeutic strategies
--  Analysis of compounds, cell therapies and devices in clinical trials
    (and abandoned) by company, mechanism of action and stage of development
    for each indication
--  Global and US market size, worldwide revenues for each indication
--  Extensive discussion of specific technological, demographic, regulatory
    and intellectual property trends

Key Topics Covered:

1: Executive Summary

--  The Brain Industry Revealed
--  Investment Risks and Opportunities

Key Industry Facts and Findings

2: Trends and Drivers

--  Converging Technology Drivers
--  Demographic Drivers
--  Social Drivers
--  Economic Drivers
--  Research Funding
--  Intellectual Property Trends

Neurotech Merger and Acquisition Activity (2005-Q1,2014)

3: Neuropharmaceutical Sector

--  Neuropharmaceutical Sector Overview
--  Neuropharmaceutical Partnering and Licensing
--  Neurology Markets and Pipelines
--  Psychiatry Markets and Pipelines
--  Sensory Markets and Pipelines

4: Stem Cells and Neuroregeneration

--  Defining Stem Cell Markets and Players
--  Stem Cell Approaches
--  Markets and Treatments in Development

5: Neurodevice Sector

--  Neurodevice Sector Overview
--  Neuroprosthetic Devices
--  Neuromodulation Devices
--  Neurosurgical devices
--  Neurosoftware
--  Therapeutic NeuroGaming

6: Neurodiagnostics Sector

--  Neurodiagnostic Sector Overview
--  Neuroimaging Technologies
--  In Vitro Diagnostics
--  Neuroinformatics

7: Private Neurotechnology Investment

--  Venture Capital Investment Trends
--  Neurotech Venture Capital Investment

8: Public Neurotechnology Investment

--  Investing in Public Neurotech Companies
--  Neurotech Initial Public Offerings
--  NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

--  Leading Neurotechnology Research Centers
--  Places to Watch

10: Leading Neurotechnology Regions

--  The Global Neurotech Economy
--  Nexus Ranking and Methodology
--  Established Neurotech Nexus
--  Emerging Neurotech Nexus
--  Nascent Neurotech Nexus
--  Conclusions and Policy Recommendations

11: Company Profiles

--  Neuropharmaceutical & Cell Therapy Companies: Private
--  Neuropharmaceutical & Cell Therapy Companies: Public
--  Neurodevice Companies: Private
--  Neurodevice Companies: Public
--  Neurodiagnostic Companies: Private
--  Neurodiagnostic Companies: Public

12: Index

For more information visit http://www.researchandmarkets.com/research/s7qvsb/the

Source: NeuroInsights

Sector: Pharmaceuticals

Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Pharmaceuticals include:

--  Pfizer, Inc.
--  Novartis International AG.
--  GlaxoSmithKline plc
--  Merck & Co., Inc.
--  Genentech Inc.
--  McKinsey & Company, Inc.
--  Novo Nordisk
--  IGEN Biotech Group AG
--  Sanofi S.A.
--  Allergan, Inc.
--  FORUM Pharmaceuticals Inc
--  Bio-Rad Laboratories
--  Bain & Company
--  Nestle Health Science
--  Pacira Pharmaceuticals, Inc
--  DBV Technologies SA
--  Chimerix, Inc.

Contacts:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
Kubernetes is an open source system for automating deployment, scaling, and management of containerized applications. Kubernetes was originally built by Google, leveraging years of experience with managing container workloads, and is now a Cloud Native Compute Foundation (CNCF) project. Kubernetes has been widely adopted by the community, supported on all major public and private cloud providers, and is gaining rapid adoption in enterprises. However, Kubernetes may seem intimidating and complex ...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, described how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launching ...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone in...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...